115 related articles for article (PubMed ID: 3199071)
1. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.
Voogt PJ; Goulmy E; Veenhof WF; Hamilton M; Fibbe WE; Van Rood JJ; Falkenburg JH
J Exp Med; 1988 Dec; 168(6):2337-47. PubMed ID: 3199071
[TBL] [Abstract][Full Text] [Related]
2. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
[TBL] [Abstract][Full Text] [Related]
3. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.
Marijt WA; Veenhof WF; Goulmy E; Willemze R; van Rood JJ; Falkenburg JH
Blood; 1993 Dec; 82(12):3778-85. PubMed ID: 8260714
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
[TBL] [Abstract][Full Text] [Related]
5. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
6. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
7. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
Tilkin AF; Bagot M; Kayibanda M; Vernant JP; Levy JP
J Immunol; 1986 Dec; 137(12):3772-6. PubMed ID: 3537123
[TBL] [Abstract][Full Text] [Related]
8. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.
Voogt PJ; Goulmy E; Fibbe WE; Veenhof WF; Brand A; Falkenburg JH
J Clin Invest; 1988 Sep; 82(3):906-12. PubMed ID: 3262125
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated lysis of human hematopoietic progenitor cells.
Voogt PJ; Fibbe WE; Veenhof WF; Brand A; Goulmy E; van Rood JJ; Falkenburg JH
Leukemia; 1987 May; 1(5):427-31. PubMed ID: 3499546
[TBL] [Abstract][Full Text] [Related]
10. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.
Voogt PJ; Fibbe WE; Marijt WA; Goulmy E; Veenhof WF; Hamilton M; Brand A; Zwann FE; Willemze R; van Rood JJ
Lancet; 1990 Jan; 335(8682):131-4. PubMed ID: 1967432
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
[TBL] [Abstract][Full Text] [Related]
12. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
13. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
14. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
[TBL] [Abstract][Full Text] [Related]
16. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
17. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
18. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.
Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK
Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472
[TBL] [Abstract][Full Text] [Related]
19. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
